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To evaluate the feasibility of a novel ‘safety-valve’ device for preventing catheter related 
urethral trauma during urethral catheterisation (UC). To assess the opinions of clinicians on 
the performance of the safety-valve device. 
 
Materials and Methods 
A validated prototype ‘safety-valve’ device for preventing catheter balloon inflation related 
urethral injuries was prospectively piloted in male patients requiring UC in a tertiary referral 
teaching hospital (n=100). The device allows fluid in the catheter system to decant through an 
activated safety threshold pressure valve if the catheter anchoring balloon is misplaced. Users 
evaluated the ‘safety-valve’ with an anonymous questionnaire. The primary outcome 
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measurement was prevention of anchoring balloon inflation in the urethra. Secondary 




Patient age was 76 ± 12 years and ASA grade was 3 ± 1.4. The ‘safety-valve’ was utilised by 
34 clinicians and activated in 7% (n=7/100) patients during attempted UC, indicating that the 
catheter anchoring balloon was incorrectly positioned in the patient’s urethra. In these 7 
cases, the catheter was successfully manipulated into the urinary bladder and inflated. 31/34 
(91%) clinicians completed the questionnaire. 10% (n=3/31) of respondents had previously 
inflated a urinary catheter anchoring balloon in the urethra and 100% (n=31) felt that a safety 
mechanism for preventing balloon inflation in the urethra should be compulsory for all UCs.  
 
Conclusion 
The safety-valve device piloted in this clinical study offers an effective solution for 
preventing catheter balloon inflation related urethral injuries. 
 
Abbreviations: 
UC: Urethral catheterisation 
TUC: Traumatic urethral catheterisation 
 
1.0 Introduction 
Approximately 25% of hospitalised patients undergo urethral catheterisation (UC) during 
their inpatient stay
1
. A misplaced urethral catheter, with subsequent inflation of its anchoring 
balloon in the patient’s urethra, is a frequently encountered complication that can lead to 
debilitating long-term co-morbidities
2,3
 Short-term complications associated with traumatic 
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UC are penile/perineal pain, urosepsis, acute urinary retention, urethral bleeding or urinary 
tract infection
1
. Long-term complications include urethral stricture disease requiring 
subsequent reconstructive procedures
3,4
. Despite these preventable iatrogenic morbidities, 
few studies examine mechanisms to prevent UC related injuries
5
. Of those that examine such 
mechanisms, none are based on data from human patients in a clinical environment
6
. The 
objective of the present study is to clinically evaluate a mechanism for preventing urinary 
catheter inflation related injuries in patients requiring UC. This is accomplished by 
prospectively performing a clinical trial of a novel ‘safety-valve’ device that is intended to 
prevent inadvertent inflation of the catheter’s anchoring balloon in the urethra during UC. We 
also aim to assess the opinions of junior doctors on the clinical performance of the safety-
valve device.   




2.1 Overview of study design 
Following hospital ethical research committee approval a previously validated prototype 
‘safety-valve’ device, that allows fluid in the catheter system to decant through an activated 
safety threshold pressure valve, was prospectively evaluated in 100 male patients requiring 
UC in a tertiary referral teaching hospital (Beaumont Hospital, Dublin, Ireland) (Fig. 1)
6
. 
Written informed consent was obtained in every patient and a patient information leaflet was 
given to every patient.  All clinicians that utilised the device were educated on its application 
through ‘hands-on’ demonstrations on silicone catheterisation models. Inclusion criteria 
included male gender, age >18 years, painless acute urinary retention, no previous history of 
urethral trauma and appropriately consented patients. Painless acute urinary retention was 
defined as a post void residual (PVR) volume measurement >400ml in the absence of 
suprapubic pain. Exclusion criteria included patients unable to provide informed consent, 
emergency catheterisations (e.g. painful acute urinary retention), paediatric patients and prior 
history of urethral trauma.  
 
2.2 Safety-valve 
The safety-valve comprises of a pressure valve and flow-restrictor that attach distally to an 
existing commercial syringe and proximally to any commercial urinary catheter (Fig. 1). The 
safety valve functions as a one-way pressure relief valve that allows pressurised fluid to flow 
from an auxiliary passage out of the system in a regulated manner. The purpose of the 
pressure valve is to prevent inflation of the catheter’s anchoring balloon when inadvertently 
misplaced in the urethra and to allow inflation when correctly positioned in the urinary 
bladder. Once the valve has ‘popped’ it automatically deactivates so that it can be used 
repeatedly. The flow restrictor prevents rapid inflation of the anchoring balloon (an act which 
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has the potential to allow a portion of the fluid to bypass the pressure valve and cause partial 
inflation of the balloon even when mispositioned) in the urethra
7
.The valve remains 
inactivated when the anchoring balloon is in the bladder allowing the anchoring balloon to 
inflate as normal.  
 
2.3 Measurement outcomes 
The primary outcome measurement was prevention of anchoring balloon inflation in the 
urethra. The secondary outcome measurement was successful inflation of the urinary 
catheter’s anchoring balloon in the bladder without dispensing fluid (false-positive). 
Successful UC was defined as urine exiting the catheter’s drainage port witnessed by the user 
with successful inflation of the catheter’s anchoring balloon. Users were instructed not to 
repeatedly attempt to inflate the catheter’s anchoring balloon if the safety-valve activated. 
Instead, they were advised to gently advance the deflated catheter until urine drained from the 
drainage port. Users that performed UC with the safety-valve were then requested to 
complete an anonymous questionnaire on their opinions of the device. The survey consisted 
of 5 questions and requested details pertaining to UC of male patients with the safety-valve. 
(Table 1). All questions required either ‘Yes’ or ‘No’ as an answer. Unless otherwise stated, 
data are represented as mean ± standard deviation (SD), and n represents the number of 
patients included in the analysis 
  





In total, 34 interns utilised the safety device in 100 consenting male patients requiring 
inpatient UC. All patients underwent successful catheterisation with the ‘safety-valve’ device. 
The relevant UC patient demographics are demonstrated in Table 2. The mean patient age 
was 76 ± 12 years and the mean ASA grade was 3 ± 1.4. Indications for UC included 
monitoring of urine output (n=68), treatment of acute urinary retention (n=25) and 
requirement of long-term indwelling urethral catheterisation (n=7). No urethral injuries due to 
traumatic catheterisation were recorded during the study time-period. The ‘safety-valve’ 
activated in 7 patients during attempted UC, indicating that the catheter’s anchoring balloon 
was incorrectly positioned in the patient’s urethra (Table 3). In these 7 cases, the catheter was 
successfully manipulated into the urinary bladder by the user followed by successful inflation 
of the anchoring balloon. 
 
3.2 Questionnaire response 
The questionnaire was completed by 31/34 (91%) interns that utilised the safety-device 
(Table 1). No questionnaires were incomplete, and analysis was performed on every returned 
questionnaire. Among the respondents, 10% (n=3/31) had previously inflated the catheter’s 
anchoring balloon in the urethra instead of the urinary bladder in a male patient. The majority 
(87 %; n = 27/31) of interns were interested in a safety mechanism for preventing urethral 
trauma during the catheterisation procedure and 100% (n = 31) felt that a safety mechanism 
for trauma prevention should be compulsory for all urethral catheterisations.  
 
  




UC is a routine procedure that is performed daily by healthcare professionals. Iatrogenic 
complications associated with UC have recently decreased due to advanced training 
programmes that are regularly provided by senior clinicians
8
. Junior doctors are supervised 
during their initial months when performing UC and a quota of catheterisations is usually 
required prior to complete independence. Although supervised training programmes have led 
to an overall decrease in the frequency of catheter-related complications, our questionnaire 
demonstrates that the anchoring balloon is mistakenly inflated in the urethra in approximately 
10% of patients among junior doctors. Therefore, a safer urethral catheter system in 
conjunction with supervised training may be necessary to eradicate the risk of unnecessary 
urethral trauma during UC. 
 
Our clinical trial also demonstrates that incorporation of a novel safety-valve device 
eliminates the potential for catheter balloon inflation related injuries to the urethra. We found 
that the safety-valve facilitates successful inflation of the urinary catheter’s anchoring balloon 
in the bladder as evidenced by successful UC of all patients. Similar significant technological 
advances have been recently described and advocated in urinary catheter device design. 
Wagner et al. introduced the concept of a vision-guided urinary catheter as an auxiliary 
device for nursing personnel in cases of difficult catheterisation
9
. Azar et al. trialled a 
recently developed atraumatic urinary catheter in an animal model
10
. The authors assessed 
their device by forcibly extracting catheters with the balloon still inflated and found no 
evidence of urethral trauma in 10/14 male rabbits. Wu et al. emphasised that urethral 
resistance pressure, intravesical pressure and catheter inflation forces (Newtons) are 
parameters that should be developed for designing an atraumatic urinary catheter. The safety 
device outlined in this present study allows fluid to decant through an activated safety valve 
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at a threshold pressure that can be tailored to specific balloon inflation pressures (e.g. 
150kPa) thereby eliminating the potential for urethral trauma
11
. This offers an advantage over 
emerging technology as it eliminates the need for vision-guidance using scientifically derived 
and clinically evaluated pressure differentials and flow resistance. This technology therefore 
offers an effective and dependable solution to a preventable iatrogenic injury. Our findings 
are clinically relevant as millions of urinary catheters are inserted annually and iatrogenic 
urethral injuries are a potentially preventable source of injury in patients
12
. Iatrogenic 
complications from UC are associated with medicolegal implications, financial penalties, 
longer inpatient stays and long-term urethral stricture disease. In addition to short-term and 
long-term iatrogenic morbidity and monetary loss, urethral injuries lead to an increased 




Globally, the most commonly used urethral catheter was devised by Foley in 1929 and its 
design was patented in 1936
13
. Since then no significant alteration has occurred for improving 
the safety design of urethral catheters
13
. The modern Foley catheter is coated with a silicone 
elastomer to reduce the potential for latex toxicity associated with the original device
8
. 
Catheter research is primarily aimed at decreasing the incidence of urinary tract infections by 
coating antiseptic or antimicrobial agents over the catheter. In view of the significant 
morbidity caused by urinary catheters, there is an obvious clinical need to provide a research 
program for developing a safer alternative
13
. Recently, the incidence, cost, complications and 
clinical outcomes of iatrogenic urethral catheterisation injuries was prospectively monitored 
across 2 tertiary referral teaching hospitals and the incidence of significant urethral trauma 
was 6.7 patients per 1,000 patients catheterised
1
. Furthermore, 81% of patients with urethral 
trauma sustained a Clavien-Dindo complication grade ≥2. The cost of managing these 
inpatient complications was €335,377 or €60 per inpatient catheterised over a 6-month 





. To decrease or eliminate the risk of urethral injury or rupture during UC, urologists 
must be willing to support safer urethral catheter design modifications such as the technology 
outlined in this study. One recent study of 130 junior doctors found that 90% would be 
interested in a safety mechanism for preventing urethral trauma and 71% felt that such a 
mechanism should be mandatory when catheterising male patients
14
. Similarly, we noted that 
100% of respondents to our questionnaire believed that a safety mechanism for preventing 
urethral trauma during UC should be compulsory when catheterising male patients.  
 
5.0 Conclusion 
A clinical trial of a novel safety-valve device intended to prevent anchoring balloon inflation 
in the urethra was piloted, using appropriate pressure differentials. No urethral injuries due to 
traumatic catheterisation were recorded. This technology therefore offers an effective and 
dependable solution to a preventable iatrogenic urethral injury.  
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Figure 1:  Urinary-catheter ‘safety-valve’ for preventing balloon related urethral 
injuries during UC 
Legend: The safety-valve attaches distally to an existing commercial syringe and 
proximally to any commercial urinary catheter (A).  If the catheter’s anchoring balloon 
is inflated in the urethra, the safety valve is activated thereby preventing inflation of 
the balloon in the incorrect position and limiting the potential for urethral trauma. The 
flow restrictor prevents rapid inflation of the anchoring balloon which can bypass the 
safety valve (B). The valve remains inactivated when the balloon is in the bladder. 
This means that the anchoring balloon can only be inflated when positioned correctly 
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Table 1: Questionnaire design and attitudes of respondents towards the urinary 





Do you feel confident inserting a transurethral catheter 
independently? 
30 (97) 1 (3) 
Have you ever inflated the catheter’s anchoring balloon in the 
urethra instead of the bladder in a male patient? 
3 (10) 28 (90) 
Would a safety mechanism that prevents urethral trauma from 
trans-urethral catheterisation interest you? 
27 (87) 4 (13) 
Did you find the safety-valve user friendly? 26 (84) 5 (16) 
Do you think a safety mechanism that prevents urethral trauma 











Page 14 of 18
15 
 
Table 2: Demographics of patients that underwent UC with the safety-valve device 
Demographic Number (n) 
Age (years) 76 ±12  
ASA grade 3 ±1.4 
Number of times safety-valve activated 7 
Indication for urethral catheterisation (n) 
Urinary retention  25 
Monitoring of urine output 68 
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Table 3: Details of patients in whom the safety-valve activated indicating a 
misplaced urinary catheter anchoring balloon. 
Legend: Three patients had a history of prostatic enlargement and 4 patients had no 
previous urological history. In 3 cases the intern documented difficulty with the 
catheterisation. These 3 patients had a known history of BPH indicating technical 
difficulties. In 4 cases the safety-valve activated in patients with no known urological 
history indicating a lack of experience of the intern. 
*BPH: benign prostatic hyperplasia, UC: urethral catheterisation 
Patient 
number 
Age Details of UC and safety-valve activation 
1 74 Known history of BPH 
Patient required UC for output monitoring post orthopaedic surgery  
Intern documented difficulty passing catheter 
2 68 Known history of BPH 
Patient required UC for PVR >400ml 
Intern documented difficulty passing catheter 
3 78 No past urological history 
Patient required UC for PVR >400ml post inguinal hernia surgery 
No difficulty documented with catheterisation 
4 75 No past urological history 
Patient required UC for urinary output monitoring post colorectal 
surgery 
No difficulty documented with catheterisation 
5 72 Known history of BPH 
Patient required UC for PVR >400ml 
Page 16 of 18
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Intern documented difficulty passing catheter 
6 75 No past urological history 
Patient required UC for output monitoring post orthopaedic surgery 
No difficulty documented with catheterisation 
7 69 No past urological history 
Patient required UC for urinary output monitoring post colorectal 
surgery 
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